Egbert R. Boevé

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

Meelan Bul, Xiaoye Zhu, R. Valdagni et al. · European Urology · 2012 · 534 citations

Urology, Cancer Epidemiology, Cancer Screening +9

Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome

Bas W.G. van Rhijn, André N. Vis, Theodorus van der Kwast et al. · Journal of Clinical Oncology · 2003 · 319 citations

<b> <i>FGFR3</i> </b> and <b> <i>P53</i> </b> Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma

Bas W.G. van Rhijn, Theodorus van der Kwast, André N. Vis et al. · Cancer Research · 2004 · 219 citations · Full text

Tumor Biology, P53 Alterations, Urology +15

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

Bas W.G. van Rhijn, Tahlita C.M. Zuiverloon, André N. Vis et al. · European Urology · 2010 · 190 citations

Urology, Cancer Risk, Urologic Cancer Epidemiology +9

<b>Positive Margins after Radical Prostatectomy: Correlation with Local Recurrence and Distant Progression</b>

D. van den Ouden, F.M. Bentvelsen, Egbert R. Boevé et al. · British Journal of Urology · 1993 · 170 citations

Urology, Surgical Oncology, Perineural Invasion +11